Benzinga | Nov 19, 2021 08:06AM EST

JMP Securities Maintains Market Outperform on Enanta Pharmaceuticals, Lowers Price Target to $111

JMP Securities analyst Jason Butler maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Market Outperform and lowers the price target from $121 to $111.